JAMI CHRZANOWSKI: Open Payments
NPI 1912236126 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 47 payments from 12 companies in 2025. Trend: 2023 $10,773 · 2024 $816 · 2025 $1,047
Food & beverage: $858Education: $189
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $212 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $206 |
| Lilly USA, LLC | 6 | $187 |
| Evofem Biosciences, Inc. | 14 | $184 |
| Amgen Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $62 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| MILLICENT US INC | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: ZEPBOUND, Phexxi, ANNOVERA, EVENITY, Wegovy, ACCRUFER, Veozah, INTRAROSA.
Industry payments across NC — which companies pay providers there.
